Published in Dig Dis Sci on June 01, 2001
The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol (2012) 1.10
Role of endogenous vitamin E in renal ischemic preconditioning process: differences between male and female rats. Iran Biomed J (2012) 0.81
The effect of estrogen on hepatic microcirculation after ischemia/reperfusion. Int J Colorectal Dis (2007) 0.79
Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol (2016) 0.77
Consequences of Ischemic Preconditioning of Kidney: Comparing between Male and Female Rats. Iran J Basic Med Sci (2012) 0.77
Effect of Γ-aminobutyric acid on kidney injury induced by renal ischemia-reperfusion in male and female rats: Gender-related difference. Adv Biomed Res (2015) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Microsomal lipid peroxidation. Methods Enzymol (1978) 16.78
Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol (1991) 2.67
Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest (1993) 1.66
The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41
Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact (1991) 1.31
Effect of donor age and sex on the outcome of liver transplantation. Hepatology (1995) 1.31
Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology (1991) 1.27
Disease gravity and urgency of need as guidelines for liver allocation. Hepatology (1994) 1.16
Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet (1995) 1.13
Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem Biophys Res Commun (1989) 1.06
Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation (1996) 1.05
Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol (1998) 1.03
O2-. release by activated Kupffer cells upon hypoxia-reoxygenation. Am J Physiol (1991) 0.97
Steroid sex hormones and macrophage function: modulation of reactive oxygen intermediates and nitrite release. Am J Reprod Immunol (1994) 0.96
Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci (1993) 0.96
Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed) (1987) 0.93
Further evidence that lucigenin-derived chemiluminescence monitors mitochondrial superoxide generation in rat alveolar macrophages. Free Radic Biol Med (1994) 0.92
The impact of gender on renal transplantation. Transplantation (1994) 0.91
Effect of estradiol upon serum enzymes in primary biliary cirrhosis. Hepatology (1987) 0.85
Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia-reperfusion injury of rat liver. Hepatology (1997) 0.83
The influence of ethanol and liver disease on sex hormones and hepatic oestrogen receptors in women. Dan Med Bull (1993) 0.83
Chemiluminescent measurement of increased free radical formation after ischemia/reperfusion. Mechanisms of free radical formation in the liver. Dig Dis Sci (1995) 0.81
Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats. Free Radic Biol Med (1998) 0.79
Reoxygenation injury in isolated rat hepatocytes: relation to oxygen free radicals and lipid peroxidation. Am J Physiol (1994) 0.77
Glutathione peroxidase activity and release of glutathione from oxygen-deficient perfused rat heart. Biochem Biophys Res Commun (1979) 0.76
Impact of donor gender on graft survival after liver transplantation. Transplant Proc (1997) 0.76
Oxygen free radical formation by rat hepatocytes during postanoxic reoxygenation: scavenging effect of albumin. Am J Physiol (1994) 0.76
Impact of donor and recipient gender on liver transplantation. Transplant Proc (1997) 0.75
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
Screening test for coeliac disease. Lancet (1997) 2.23
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria. Gastroenterology (1993) 2.15
Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet (2000) 2.13
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Aliment Pharmacol Ther (2011) 2.12
Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer (1995) 2.11
Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther (2004) 2.09
Hydrogen peroxide-related colitis (previously known as "pseudolipomatosis"): a series of cases occurring in an epidemic pattern. Endoscopy (2007) 2.07
Atypical sarcoidosis: case reports and review of the literature. Eur Rev Med Pharmacol Sci (2009) 1.98
Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther (2003) 1.88
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (2006) 1.76
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2002) 1.73
Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet (1995) 1.68
Reference values for respiratory rate in the first 3 years of life. Pediatrics (1994) 1.65
Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol (2000) 1.63
Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol (1992) 1.62
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci (1998) 1.61
Caudal blockade as alternative therapeutic approach in neonatal arterial thrombosis. Eur J Pediatr (2001) 1.61
Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol (1999) 1.60
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther (2003) 1.59
Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors. J Mol Cell Cardiol (2004) 1.59
Bone mass and metabolism in patients with celiac disease. Gastroenterology (1995) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Do internal mammary artery side-branches have the potential for haemodynamically significant flow steal? Eur J Cardiothorac Surg (1999) 1.56
Methodology of the H2 breath test. II. Importance of the test duration in the diagnosis of carbohydrate malabsorption. Ital J Gastroenterol (1990) 1.55
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.54
Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol (1998) 1.54
Howell-Jolly body counting as a measure of splenic function. A reassessment. Clin Lab Haematol (1990) 1.54
Steal phenomenon from mammary side branches: when does it occur? Ann Thorac Surg (1998) 1.53
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther (2001) 1.52
Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology (1982) 1.52
Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol (1997) 1.52
Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital J Gastroenterol Hepatol (1998) 1.50
Cirrhotic cardiomyopathy. Dig Liver Dis (2007) 1.49
Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time. Int J Clin Pract (2006) 1.45
The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg (2002) 1.43
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Ageing affects anoxia/reoxygenation injury in rat hepatocytes. Scand J Gastroenterol (1998) 1.42
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study. Ital J Gastroenterol Hepatol (1999) 1.41
Doppler ultrasound evaluation of acute effects of cigarette smoking on portal blood flow in man. J Gastroenterol Hepatol (1996) 1.40
Dicarboxylic acids and glucose utilization in humans: effect of sebacate. JPEN J Parenter Enteral Nutr (1994) 1.40
Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease. Eur J Gastroenterol Hepatol (2000) 1.39
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis (2005) 1.39
Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia. Scand J Gastroenterol (1995) 1.39
[Whipple's disease: progress in the diagnosis and review of the literature]. Minerva Med (2002) 1.38
Acquired gastric mucosa-associated lymphoid tissue (MALT): a review with special emphasis on association with extragastric diseases and management problems of gastric MALT. J Clin Gastroenterol (1999) 1.38
Substrate supply as determinant of O2 extraction in sepsis and nonseptic trauma. Nutrition (1993) 1.38
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. Alcohol Clin Exp Res (2000) 1.38
An 18-year-old woman with familial chylomicronaemia who would not stick to a diet. Lancet (1996) 1.37
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis (2007) 1.36
DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease. Gut (1985) 1.35
Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci (2009) 1.31
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: a comparison between linear measurement, stereology, and computer aided microscopy. J Clin Pathol (1985) 1.30
Anisakis infestation: a case of acute abdomen mimicking Crohn's disease and eosinophilic gastroenteritis. Dig Liver Dis (2005) 1.27
Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism (2000) 1.27
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology (2001) 1.25
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.24
State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract (2008) 1.23
Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence. Alcohol Clin Exp Res (2000) 1.20
Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis. J Clin Gastroenterol (1993) 1.20
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther (2005) 1.19
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther (2002) 1.19
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2007) 1.17
Gluten specific suppressor T cell dysfunction in coeliac disease. Gut (1986) 1.17
Probiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study. Digestion (2004) 1.17
Cutaneous manifestations in celiac disease. World J Gastroenterol (2006) 1.16
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther (2000) 1.16
Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol (1998) 1.16